574
Participants
Start Date
September 30, 2009
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Epirubicin + cisplatin + 5-fluorouracil OR epirubicin + cisplatin + capecitabine OR epirubicin + oxaliplatin + capecitabine OR 5-Fluorouracil + leucovorin + oxaliplatin + docetaxel
"Epirubicin 50 mg/m2 IV day 1, cisplatin 60 mg/m2 IV day 1, 5-fluorouracil 200 mg/m2/d IV 21 day continuous infusion (ECF chemotherapy).~Epirubicin 50 mg/m2 IV day 1, Cisplatin 60 mg/m2 IV day 1, Capecitabine (X = Xeloda) 625mg/m2, bid days 1-21 (ECX chemotherapy)~Epirubicin 50mg/m2 IV day 1, Oxaliplatin (O) 130mg/m2 IV day 1, Capecitabine 625mg/m2, bid days 1-21 (EOX chemotherapy)~5-Fluorouracil 2600 mg/m² IV 24 h infusion day 1, Leucovorin (L) 200 mg/m² IV day 1, Oxaliplatin 85 mg/m² IV day 1, Docetaxel (T) 50 mg/m² IV day 1 (FLOT chemotherapy)"
Preoperative chemoradiotherapy
"Chemotherapy: Continuous infusional 5-fluorouracil 200mg/m2/day, 7 days per week, throughout the entire period of radiotherapy or capecitabine 825 mg/m2, oral tablet twice daily, days 1-5 of each week of radiotherapy (without weekends).~Radiotherapy: 45 Gy of radiation in 25 fractions, five days per week for five weeks."
Gastric resection
The acceptable resections are a total gastrectomy, a subtotal gastrectomy, and an esophagogastrectomy (Ivor-Lewis esophagogastrectomy for gastroesophageal junction cancers \[Siewert Type II and Siewert Type III\] invading up to but no more than 2cm of the lower esophagus). The minimum extent of the operation should be a D1+ lymph node dissection but it is recommended that a D2 dissection be performed or a D1+ for gastroesophageal junction cancers requiring an esophagogastrectomy.
AZ Turnhout- Campus Sint Elisabeth, Turnhout
Universitair Ziekenhuis Antwerpen, Edegem
AZ Klina, Brasschaat
U.Z Leuven Campus Gasthuisberg, Leuven
Centre Hospitalier Peltzer- La Tourelle, Verviers
Hospital De Jolimont, La Louvière
AZ Damiaan, Ostend
CHRU de Besancon Hopital Jean Minjoz, Besançon
Rambam Medical Center, Haifa
Hospital Clinico Universitario De Valencia, Valencia
The Institute of Oncology, Ljubljana
Tel Aviv Sourasky Medical Center, Tel Aviv
Centre Paul Strauss, Strasbourg
Klinikum der Universitaet Muenchen - Campus Grosshadern, München
Institut Sainte Catherine, Avignon
Calvary Mater Newcastle, Newcastle
Chris O Brien Lifehouse, Sydney
Liverpool Hospital, Sydney
Nepean Hospital, Sydney
Prince of Wales Hospital, Sydney
Royal North Shore Hospital, Sydney
St George Hospital, Sydney
Westmead Hospital, Sydney
The Tweed Hospital, Tweed Heads
Wollongong Hospital, Wollongong
Princess Alexandra Hospital, Brisbane
Flinders Medical Centre, Adelaide
Royal Hobart Hospital, Hobart
Launceston General Hospital, Launceston
Geelong Hospital, Geelong
Austin Hospital, Melbourne
Monash Medical Centre, Melbourne
Peter MacCallum Cancer Centre, Melbourne
St Vincent's Hospital, Melbourne
Sunshine Hospital (Western Health), Melbourne
Sir Charles Gairdner Hospital, Nedlands
BCCA - Vancouver Centre, Vancouver
Cancer Care Manitoba, Winnipeg
Royal Victoria Regional Health Centre, Barrie
Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston
Grand River Regional Cancer Center, Kitchener, Kitchener
London Regional Cancer Program, London
Ottawa Health Research Institute, Ottawa
Odette Cancer Centre, Sunnybrook Hospital, Toronto
UHN - Princess Margaret Hospital, Toronto
Hopital Maisonneuve-Rosemont, Montreal
Hospital Notre-Dame, Montreal
Jewish General Hospital, Montreal
Centre hospitalier universitaire de Sherbrooke, Sherbrooke
Allan Blair Cancer Centre, Regina
Saskatoon Cancer Centre, Saskatoon
Auckland Hospital, Auckland
Dunedin Hospital, Dunedin
Waikato Hospital, Hamilton
Institut Catala d Oncologia - ICO Badalona - Hospital Germans Trias i Pujol, Badalona
Charles University Hospital, Hradec Králové
Centre Hospitalier de Belfort Montbeliard site du Mittan, Montbéliard
ICO L Hospitalet Hospital Duran i Reynals (Institut Catala D Oncologia), L'Hospitalet de Llobregat
Vall D Hebron University Hospital, Barcelona
Collaborators (1)
National Health and Medical Research Council, Australia
OTHER
Trans Tasman Radiation Oncology Group
OTHER
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK
NCIC Clinical Trials Group
NETWORK
Australasian Gastro-Intestinal Trials Group
NETWORK